Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Clinical trial NCT00998946 · COMPLETED
Trial details
- NCT number
- NCT00998946
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2012-08-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.